We are live on ! Find out more
AG

Artal Group Portfolio holdings

AUM $1.01B
1-Year Est. Return 29.84%
This Fund
S&P 500
This Quarter Est. Return
-15.88%
1 Year Est. Return
+29.84%
3 Year Est. Return
+144%
5 Year Est. Return
+76.57%
10 Year Est. Return
+1,417.6%
AUM
$4.48B
AUM Growth
+$2.15B
Cap. Flow
+$2.99B
Cap. Flow %
66.91%
Top 10 Hldgs %
76.84%
Holding
89
New
19
Increased
22
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
BUFF
Blue Buffalo Pet Products, Inc
BUFF
+$2.82B
2
BLUE
bluebird bio
BLUE
+$16.2M
3
YUM icon
Yum! Brands
YUM
+$12.6M
4
MS icon
Morgan Stanley
MS
+$9.1M
5
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.35M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$32.9M
2
MBLY
Mobileye N.V.
MBLY
+$26.6M
3
AER icon
AerCap
AER
+$17.2M
4
AAL icon
American Airlines Group
AAL
+$16M
5
BABA icon
Alibaba
BABA
+$14.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 46.01%
2 Healthcare 19.71%
3 Consumer Discretionary 5.21%
4 Financials 1.51%
5 Communication Services 0.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
26
DELISTED
bluebird bio
BLUE
$26.9M 0.6%
24,318
+8,878
+58% +$16.2M
QCOM icon
27
CALL
Qualcomm
QCOM
$164B
$26.9M 0.6%
500,000
– –
TEVA icon
28
CALL
Teva Pharmaceuticals
TEVA
$40.4B
$25.4M 0.57%
450,000
– –
MRK icon
29
CALL
Merck
MRK
$322B
$24.7M 0.55%
524,000
– –
LNKD
30
DELISTED
LinkedIn Corporation
LNKD
$23.8M 0.53%
125,000
-6,500
-5% -$1.29M
AAPL icon
31
CALL
Apple
AAPL
$4.96T
$22.1M 0.49%
+800,000
New +$23.5M
KITE
32
DELISTED
Kite Pharma, Inc.
KITE
$21.7M 0.49%
390,000
-35,000
-8% -$2.2M
YUM icon
33
CALL
Yum! Brands
YUM
$41.9B
$20M 0.45%
347,750
-347,750
-50% -$21M
NKTR icon
34
Nektar Therapeutics
NKTR
$2.39B
$19.7M 0.44%
120,000
+6,667
+6% +$1.18M
MCD icon
35
CALL
McDonald's
MCD
$193B
$19.7M 0.44%
200,000
– –
BABA icon
36
Alibaba
BABA
$276B
$17.7M 0.4%
300,000
-200,000
-40% -$14.5M
ARRY
37
DELISTED
Array Biopharma Inc
ARRY
$16.9M 0.38%
3,710,000
– –
IONS icon
38
Ionis Pharmaceuticals
IONS
$8.93B
$16.2M 0.36%
400,000
– –
AGIO icon
39
Agios Pharmaceuticals
AGIO
$2.08B
$15.9M 0.35%
225,000
+65,000
+41% +$6.35M
CCI icon
40
CALL
Crown Castle
CCI
$34.6B
$15.8M 0.35%
200,000
– –
BAC icon
41
Bank of America
BAC
$429B
$15.6M 0.35%
1,000,000
– –
HAPN
42
Happen Inc
HAPN
$2.14B
$15.5M 0.35%
235,000
+20,000
+9% +$1.36M
MU icon
43
CALL
Micron Technology
MU
$835B
$15M 0.33%
1,000,000
– –
GM icon
44
General Motors
GM
$80.9B
$13.5M 0.3%
450,000
– –
AMZN icon
45
CALL
Amazon
AMZN
$2.44T
$12.8M 0.29%
+500,000
New +$12.6M
YUM icon
46
Yum! Brands
YUM
$41.9B
$12M 0.27%
+208,650
New +$12.6M
BMRN icon
47
CALL
BioMarin Pharmaceuticals
BMRN
$11.9B
$10.5M 0.24%
100,000
-100,000
-50% -$13.4M
TWX
48
CALL
DELISTED
Time Warner Inc
TWX
$10.3M 0.23%
+150,000
New +$11.8M
JUNO
49
DELISTED
Juno Therapeutics, Inc.
JUNO
$9.56M 0.21%
235,000
+45,000
+24% +$1.97M
KITE
50
CALL
DELISTED
Kite Pharma, Inc.
KITE
$8.35M 0.19%
+150,000
New +$9.44M
1
2
3 4

Similar funds

BCM
Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Artal Group's Q3 2015 Portfolio in Review

As of Q3 2015, Artal Group held 89 positions worth $4.48B, up 93% from $2.32B the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Artal Group deployed $2.99B of net new capital in Q3 2015, opening 19 new positions and adding to 22 existing holdings. Its largest new stake was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.

By sector, the portfolio is most concentrated in Consumer Staples at 46% of assets, up from 0% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $14.5M trimmed.

  • Artal Group's largest Q3 2015 buy was Blue Buffalo Pet Products, Inc: 114,987,547 shares worth $2.06B.
  • Artal Group added most to bluebird bio in Q3 2015, an estimated $16.2M increase.
  • Artal Group's biggest Q3 2015 reduction was Alibaba, cutting an estimated $14.5M.
  • Artal Group fully exited Amazon in Q3 2015, selling an estimated $32.9M.
  • Artal Group's ten largest holdings make up 77% of its $4.48B portfolio in Q3 2015.
  • Artal Group opened 19 new positions and closed 13 in Q3 2015.
  • Artal Group's portfolio value rose 93% quarter-over-quarter to $4.48B.

Based on Artal Group's 13F filing for Q3 2015, filed 13 Nov 2015.